Delivery Order SPE2DR25D2213-SPE2DR26F6CUK
- Not listed
- The Defense Logistics Agency awarded a $7,966.52 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price contract, with an ultimate completion date of July 24, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,231.88 on November 3, 2025, under a firm fixed-price contract. The order covers Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a conjugate meningococcal vaccine, with delivery required by November 4, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with a ceiling value of $18,340.29. This firm fixed-price delivery order, which must be completed by September 16, 2025, was awarded competitively with no set-aside designation. The award was issued from Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $8,177.53 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML, a meningococcal vaccine. The contract is a firm fixed price delivery order with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a competitive procurement with no set-aside designation and falls under...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $184,782 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML vaccine product. The order is scheduled for completion by October 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a small component of AmerisourceBergen's extensive pharmaceutical distribution services to federal...
- The Defense Logistics Agency awarded a $165,523.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract, which was not set-aside and competitively awarded, is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.66 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award was made on May 16, 2025, with an ultimate completion date of May 19, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $43,115.10 delivery order to AmerisourceBergen Drug Corp for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine product. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive, non-set-aside award executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed in...
- SPE2DR25D2213Indefinite Delivery Contract
- SPE2DR25D2213-SPE2DR26F6CUKDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,087.40 delivery order on November 5, 2025, for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The award, which has no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of November 6, 2025, and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child award issued under a larger contract vehicle. This award falls under AmerisourceBergen Drug Corp's broader relationship with the Defense Logistics Agency Medical Supply Chain, where the company serves as a critical pharmaceutical distributor supporting military and federal healthcare systems. AmerisourceBergen holds a substantial $999.99 billion indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) through December 2026, which serves as the primary vehicle enabling the company to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies globally to support military healthcare programs. As a non-set-aside, competitively awarded contract, this delivery order demonstrates AmerisourceBergen's continued capability to fulfill federal medical procurement requirements and supply essential vaccines to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 11/5/25 |